Network officials also said voters should expect more of a Koch focus on grassroots activism throughout the 2020 election cycle.Politicsread more
In a room full of avowed capitalists, policies that sound to some like socialism are bound not to go over well.Delivering Alpharead more
GM's usage of temporary workers, potential closure of plants and health care contributions remain major sticking points, according to people familiar with the talks.Autosread more
Republicans and Democrats have long since separated themselves by ideology, leaving each more uniformly conservative or liberal than ever. And now a new data analysis by the...Politicsread more
A Missouri man died of vaping-related illness, officials announced Thursday.Health and Scienceread more
At least in terms of monetary policy, Pence says should be taking after other regions who keep their benchmark interest rates near zero.Delivering Alpharead more
AT&T isn't focused on selling or divesting DirecTV, despite pressure from stakeholder Elliott Management, sources tell CNBC.Technologyread more
Patrick Shyu, a former tech lead at Google, has posted a series of videos making fun of Facebook, where he worked as a software engineer until last month.Technologyread more
The measure to keep the government running through Nov. 21 now heads to the Senate, where McConnell has signaled he will back a temporary spending plan.Politicsread more
Amazon's purchase comes as part of its plan to convert its delivery fleet to 100% renewable energy by 2030. The e-commerce retailer already runs 40% of its fleet on renewable...Autosread more
As part of the plan, Amazon has agreed to purchase 100,000 electric delivery vans from vehicle manufacturer Rivian.Technologyread more
If Republican members of the Senate Committee on Health, Education, Labor and Pensions expected to spend an entire hearing discussing the price of medicines on Tuesday, they were in for a surprise.
"I'm not going to ask any questions of the panel," Democratic Sen. Chris Murphy ,of Connecticut said when he gained the floor. He, like most of his Democratic colleagues, focused instead on what they called the "secret Republican health plan," being negotiated behind closed doors without bipartisan input.
President Donald Trump met Tuesday with 13 GOP senators to discuss the health-care bill, including HELP committee Chairman Lamar Alexander, who disappeared from the drug pricing hearing midway through.
Democratic Sens. Elizabeth Warren, Patty Murray, Al Franken, Murphy and others refused to focus on the stated topic of Tuesday's hearing, called "The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay."
"Let's be blunt," a clearly agitated Warren said during the hearing. "It is insane to have a bipartisan hearing on drug prices while the GOP is writing a secret bill to take away prescription drug benefits."
"I hope eventually we can sit down and have a conversation about drug pricing that is meaningful and relevant," he said. "But this is irrelevant ... if 23 million Americans lose access to health insurance, they can't afford prescription drugs. So it doesn't really matter what we do."
A Senate aide told Axios on Monday, referring to the lack of a public draft of the health-care bill, that "We aren't stupid. ... We are still in discussions about what will be in the final product so it is premature to release any draft absent further member conversations and consensus."
Senate Majority Leader Mitch McConnell, R-Ky., on Tuesday would not say when he expected the health-care bill to be released or a vote to be held.
Some observers suggested the Democratic senators' approach implies drug pricing legislation isn't a current priority for Congress.
"As evidenced that drug pricing is on the backburner, ranking member Patty Murray focused on GOP's ACA-repeal plan in her opening statement," Brian Rye, government policy analyst at Bloomberg Intelligence, tweeted during the meeting.
That may be a relief for drug stocks — a key concern for the drug industry has been that government action on pricing would result in price controls that would cap industry profits. Trump, before he took office, said a number of times he didn't understand why the U.S. doesn't negotiate on the price of drugs.
Democrats though, who have largely championed the issue of prescription drug prices, will still have two more chances to home in on it: Tuesday's hearing was the first of three planned on the topic this year, said Alexander, before he left for the Republican meeting on the health-care bill.
— CNBC's Kayla Tausche contributed to this report.